Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11232628 | 0.97 | LMNA (0.51) | SMN1; SMN2LMNAPDE4AKDM4ECYP2C19 | |
| SCHEMBL11224662 | 0.95 | SMN1; SMN2 (0.60) | SMN1; SMN2LMNAPDE4AKDM4ECYP2C19 | |
| SCHEMBL11523450 | 0.92 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAPDE4AKDM4ECYP2C19 | |
| SCHEMBL11524954 | 0.91 | LMNA (0.46) | SMN1; SMN2LMNAPDE4ACYP2C19HIF1A | |
| SCHEMBL11217136 | 0.91 | SMN1; SMN2 (0.45) | SMN1; SMN2LMNAPDE4A | |
| SCHEMBL11526793 | 0.90 | LMNA (0.45) | SMN1; SMN2LMNAPDE4ACYP2C19HIF1A | |
| SCHEMBL11232347 | 0.89 | LMNA (0.44) | SMN1; SMN2LMNAPDE4ACYP2C19HIF1A | |
| SCHEMBL11219689 | 0.86 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNACYP2C19HIF1A | |
| SCHEMBL11218610 | 0.85 | LMNA (0.43) | SMN1; SMN2LMNACYP2C19HIF1A | |
| Ioglucol SCHEMBL3153740 | 0.84 | CYP2C19 (0.42) | SMN1; SMN2LMNACYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105120908-B | The improved solidification of hardenable bone substitute | 骨支撑股份公司 | 2018-04-27 | — | — | CN | claimed |
| CN-107660153-A | Biphase ceramics bone substitute | 骨支撑股份公司 | 2018-02-02 | — | — | CN | claimed |
| CN-105120908-A | Improved setting of hardenable bone substitute | BONE SUPPORT AB | 2015-12-02 | — | — | CN | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| CN-1878516-B | Device for providing cancellous bone with bone substitute or bone reinforcing material | BONE SUPPORT AB | 2011-02-16 | — | — | CN | claimed |
| CN-1972648-B | Device for producing a hardenable mass | BONE SUPPORT AB | 2011-02-09 | — | — | CN | claimed |
| CN-101790410-A | From water soluble compound, remove silica by nanofiltration and RP chromatography | MALLINCKRODT INC | 2010-07-28 | — | — | CN | claimed |
| EP-1829565-B1 | A new bone mineral substitute | BONE SUPPORT AB (SE) | 2010-02-17 | — | — | EP | claimed |
| CN-101107021-A | Combinations comprising signal providing agents, implant materials and drugs | CINV AG (DE) | 2008-01-16 | — | — | CN | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| EP-0703790-B1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO SPA (IT) | 2000-08-16 | — | — | EP | claimed |
| US-5660814-A | Iodinated paramagnetic chelates, and their use as contrast agents | DIBRA S.P.A. (IT) | 1997-08-26 | — | — | US | claimed |
| EP-0703790-A1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO S.p.A. (IT) | 1996-04-03 | — | — | EP | claimed |
| WO-1994027644-A1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO S.P.A. (IT) | 1994-12-08 | — | — | WO | claimed |
| EP-0414288-B1 | Contrast media | NYCOMED IMAGING AS (NO) | 1994-03-23 | — | — | EP | claimed |
| US-5242683-A | Gastrointestinal tract, side effect reduction | NYCOMED IMAGING AS (NO) | 1993-09-07 | — | — | US | claimed |
| EP-0473729-A1 | CONTRAST MEDIA | NYCOMED AS (NO) | 1992-03-11 | — | — | EP | claimed |
| EP-0414288-A1 | Contrast media | NYCOMED IMAGING AS (NO) | 1991-02-27 | — | — | EP | claimed |
| WO-1991001149-A1 | CONTRAST MEDIA | NYCOMED AS (NO) | 1991-02-07 | — | — | WO | claimed |